ArticleCells2018

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs.

Mohamed Altai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.